Collectively, these results suggest that Dectin-1 expression is upregulated and associated with disease progression in GC, and the infiltration of Dectin-1+ cells combined with the TNM stage can effectively improve the ability to predict the prognosis of GC patients. This evidence concerns the gene CLEC7A and gastric cancer.